Simple purification of Escherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon

Hye Soon Won, Jeewon Lee, In Ho Kim, Young Hoon Park

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Simple procedures have been devised for purifying recombinant human interleukin-2 (hIL-2), which was expressed in Escherichia coli using sequences of glucagon molecules and enterokinase cleavage site as an N-terminus fusion partner. The insoluble aggregates of recombinant fusion protein produced in E. coli cytoplasm were easily dissolved by simple alkaline pH shift (8→12→8). Following enterokinase cleavage, the recombinant hIL-2 was finally purified by one-step reversed-phase HPLC with high purity. The ease and high efficiency of this simple purification process seem to mainly result from the role of used glucagon fusion partner, which could be applied to the production of other therapeutically important proteins.

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalBiotechnology and Bioprocess Engineering
Volume5
Issue number1
DOIs
Publication statusPublished - 2000
Externally publishedYes

Keywords

  • Glucagon
  • Human interleukin-2
  • N-terminus fusion
  • Purification process

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Simple purification of Escherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon'. Together they form a unique fingerprint.

  • Cite this